Douglas Golenbock

Douglas Golenbock

University of Massachusetts Medical School at Worcester - Worcester / United States
Others
AD Scientific Index ID: 1300261
University of Massachusetts Chan Medical School
person_outline Douglas Golenbock's MOST POPULAR ARTICLES
1-) Neuroinflammation in Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseMT Heneka, MJ Carson, J El Khoury, GE Landreth, F Brosseron, ...The Lancet Neurology 14 (4), 388-405, 201540682015
2-) IKKε and TBK1 are essential components of the IRF3 signaling pathwayKA Fitzgerald, SM McWhirter, KL Faia, DC Rowe, E Latz, DT Golenbock, ...Nature immunology 4 (5), 491-496, 200329602003
3-) The NALP3 inflammasome is involved in the innate immune response to amyloid-βA Halle, V Hornung, GC Petzold, CR Stewart, BG Monks, T Reinheckel, ...Nature immunology 9 (8), 857-865, 200824282008
4-) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceMT Heneka, MP Kummer, A Stutz, A Delekate, S Schwartz, ...Nature 493 (7434), 674-678, 201327462013
5-) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transductionJC Chow, DW Young, DT Golenbock, WJ Christ, F GusovskyJournal of Biological Chemistry 274 (16), 10689-10692, 199925191999